Meningitis Lawsuit

Rare Fungal Meningitis outbreak threatens 13,000 patients, sickens 331 people in Nine States, Kills 25
13,000 People in 23 states at Risk

Our Law Firm is seeking to represent people impacted by this outbreak. We have spoken to dozens of people and are investigating potential claims now.

Have you or a loved one recently been diagnosed with Fungal Meningitis?
Recently have an Epidural Steroid Shot? The injections Started May 21, 2012 and continued through June, July, August, September, and October 2012?
Has your Doctor Informed you that received an epidural injection that might put you at Risk?

Did you have your shot at one of these facilties? >> Current CDC Complete List

Call Our Law Firm Now: Nearly 18,000 recalled Tainted Vials are alleged to have come from New England Compounding Center in Framingham, Mass. Three large shipped lots of preservative-free methylprednisolone acetate from May 21, 2012 on, have been recalled and are likely the cause of the deadly outbreak of rare fungal meningitis.

This outbreak of a rare and deadly form of meningitis was first detected among patients treated at the Saint Thomas Outpatient Neurosurgery Center. Symptoms of Meningitis include fever, headache, nausea and neurological problems.

The Centers for Disease and Control and Prevention (CDC) and Food and Drug Administration (FDA) warned the public and doctors not to use any products manufactured by the New England Compounding Center in Framingham, MA due to an outbreak of fungal meningitis.

Patients who have meningitis related to these these shots events may be entitled to substantial compensation. 

Contact Attorney Bill Kyros now to discuss your legal options, Toll Free at 1-800-932-2921 for a Free Case Evaluation

Your Name
Phone Number(s)


City, State, Zip

Email Address

Have you or Loved one been diagnosed with Meningitis ?

Date of Diagnosis?

Where where you treated ?

Informal Case Description


LawyerViews Home

Kyros Law Offices
Boston, MA


All contents copyright 2012 Voted the #1 Web Site development company in the Lawyers Weekly Readers Choice poll.